Look Who’s On the Move!

      Alchemab Appoints Young T. Kwon as Chief Executive Officer

      WALTHAM, Mass. & CAMBRIDGE, England--(BUSINESS WIRE)--Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient...

      Stablix Appoints Eddine Saiah Chief Scientific Officer and Expands Leadership Team

      NEW YORK--(BUSINESS WIRE)--Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization (TPS) as a novel therapeutic modality, today announced that Eddine Saiah, Ph.D., has...

      Antibe Therapeutics Appoints New Board Chair and Corporate Vice Chairs

      TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target...

      Therapeutic Solutions International Recruits Dr. Donald Banerji to Scientific Advisory Board

      OCEANSIDE, Calif.--(BUSINESS WIRE)--Therapeutic Solutions International announced today the appointment of Dr. Donald Banerji to the Company’s Scientific Advisory Board. Dr. Banerji joins internationally renowned opinion...

      Chau Khuong Joins Catalio Capital Management as General Partner

      NEW YORK--(BUSINESS WIRE)--Catalio Capital Management, LP (“Catalio”), a leading multi-strategy life sciences investment firm, today announced that Chau Khuong, who was most recently a...

      Recent Articles

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.